Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma

Overview of attention for article published in Brazilian Journal of Medical and Biological Research, January 2023

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (51st percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 793 followers.

Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma https://t.co/UdXMOtQnxR

Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma https://t.co/43Xkj8hfav https://t.co/YBnmfcIWTP

Preclinical study of LMP1-RNAi-based anti-tumor therapy in EBV-positive nasopharyngeal carcinoma https://t.co/ThAurBmFg6

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.